Dr. Alencar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
CRB - Clinical Research Building
1120 NW 14th Street, Suite 610H
Miami, FL 33136Phone+1 305-243-4372Fax+1 305-243-9161
Clinical Expertise
- Malignant Hematology, Hematologic oncology, Oropharyngeal lymphoma, Angiocentric lymphoma, Non-Hodgkin lymphoma, Acute lymphoid leukemia, Primary intraocular lymphoma, Hodgkin's lymphoma
Education & Training
University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 2006 - 2009- University of Miami/Jackson Health SystemResidency, Internal Medicine, 2003 - 2006
OtherClass of 2002
Certifications & Licensure
FL State Medical License 2012 - 2026
NM State Medical License 2009 - 2014
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacodynamics of Entospletinib in Adults With Relapsed or Refractory Hematologic Malignancies Start of enrollment: 2013 Mar 14
- Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab in Adults With Previously Untreated Chronic Lymphocytic Leukemia Start of enrollment: 2014 Feb 05
Publications & Presentations
PubMed
- A First-in-Human Phase I Study of LOXO-338, an Oral Selective Bcl-2 Inhibitor, in Patients With Advanced Hematologic Malignancies.Michal Kwiatek, Guru Subramanian Guru Murthy, Marc Hoffmann, Benoit Tessoulin, Alexey Danilov
Clinical Lymphoma, Myeloma & Leukemia. 2025-01-28 - 1 citationsPirtobrutinib monotherapy in Bruton tyrosine kinase inhibitor-intolerant patients with B-cell malignancies: results of the phase I/II BRUIN trial.Nirav N Shah, Michael Wang, Lindsey E Roeker, Krish Patel, Jennifer A Woyach
Haematologica. 2025-01-01 - 1 citationsLoncastuximab tesirine with rituximab in patients with relapsed or refractory follicular lymphoma: a single-centre, single-arm, phase 2 trial.Juan Pablo Alderuccio, Alvaro J Alencar, Jonathan H Schatz, Russ A Kuker, Georgios Pongas
The Lancet. Haematology. 2025-01-01
Press Mentions
Sylvester Cancer Researchers Share Findings in Oral Presentations at the ASH 2024 Annual Meeting & Exposition - Tip SheetNovember 13th, 2024- Sylvester Cancer Researchers Share Findings in Oral Presentations at the ASH 2024 Annual Meeting & Exposition – Tip SheetNovember 13th, 2024
- Sylvester Cancer Tip Sheet: Researchers Present Posters at the 66th ASH Annual Meeting & ExpositionNovember 13th, 2024
- Join now to see all
Professional Memberships
- Member
- Member
Other Languages
- Spanish, French, Italian, Portuguese
External Links
- Sylvester Comprehensive Cancer Centerhttp://uhealthsystem.com/doctors/profile/97420
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
